Nephros, Inc.
NEPH
$4.19
$0.010.24%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 202.55% | 155.70% | 104.70% | 49.48% | 21.91% |
Total Depreciation and Amortization | -19.89% | -26.29% | -35.98% | -29.82% | 8.64% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -34.09% | -39.02% | -49.94% | 18.23% | 47.70% |
Change in Net Operating Assets | 68.77% | -384.59% | -418.44% | -269.71% | -208.35% |
Cash from Operations | 335.50% | 514.88% | -159.49% | -333.95% | -376.22% |
Capital Expenditure | 100.00% | 26.67% | 26.67% | -- | -- |
Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 100.00% | 33.33% | 33.33% | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 57.14% | 42.86% | 93.67% | 95.51% | 95.51% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 57.14% | 42.86% | 93.67% | 96.26% | 96.26% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 303.47% | 320.69% | -181.28% | -417.45% | -916.67% |